Use of continuous glucose monitors in low‐ and middle‐income countries: A scoping review
Authors' conclusion
The scoping review identified that studies about CGMs in LMICs have several limitations. Stronger study designs, appropriate sample sizes and the inclusion of patient-important outcomes should be considered to inform the evidence about CGMs for the management of people with diabetes in LMICs.
Study context
- Population
- Original research on CGM use in Low- and Middle-income Countries (LMICs) (T1D, T2D, GDM); Medline, Embase, Global Health, Scopus; English, Portuguese, Spanish, French
- Participants
- 27 reports
- Outcome
- Included reports
Methodological detailsnarrative synthesis, two independent reviewers
- Narrative synthesis
- Two independent reviewers
Main finding
As reported in the abstract
- Records found in database search
- 4772
- Reports included
- 27
- Reports from China
- 7
- Reports from Colombia
- 5
- Reports from India
- 4
- Reports on T1D
- 13
- Reports on T2D
- 5
- Reports on both T1D and T2D
- 7
- Reports on GDM
- 2
- Experimental studies (5 randomized trials, 2 quasi-experimental)
- 7
- Cost-effectiveness analyses
- 2
- Observational studies
- 18
Original publication
Use of continuous glucose monitors in low‐ and middle‐income countries: A scoping review. Diabet Med. Published 23 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →